key: cord-1002939-qkv5ulsy authors: Rathinasamy, Muthusami; Kandhasamy, Saritha title: An exploratory study on the propagation of SARS‐CoV‐2 variants: Omicron is the most predominant variant date: 2022-02-26 journal: J Med Virol DOI: 10.1002/jmv.27634 sha: b888fd26ac1a04a13f912b7faa7c724d678fc347 doc_id: 1002939 cord_uid: qkv5ulsy As severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) evolves, it accumulates mutations, which are changes in the genetic code. Because this virus has built‐in RNA repair mechanisms, it generates mutations more slowly than some other RNA viruses. Thousands of mutations have emerged since the beginning of the pandemic throughout all virus genomes sequenced to date, resulting in thousands of distinct variants. However, some variants have recently been discovered that appear to increase transmissibility and may affect illness pervasiveness. In this study, we investigated SARS‐CoV‐2 variants and how countries intervene with them. We also depicted the top 25 countries where the Omicron variant is prevalent, with the UK, US, Denmark, France, and Australia having the top five places as of January 13, 2022. The perception of SARS‐CoV‐2 variants was investigated in those five countries, and the propagation rate of the Omicron variant was determined to be 51%, 29%, 26%, 15%, and 44%, respectively, indicating that the Omicron variant is the most prevalent among the others. Then, a study of SARS‐CoV‐2 infection test rate based on tests conducted per one million populations with a number of sequences in those five countries reveals that 25%, 73%, 1.6%, 4.8%, and 1.5%, respectively, it suggests that viral testing should be increased in all five countries since it will help to determine the precise distribution of variants and aid governments in making policy decisions for public safety. We anticipated the production of new variants strains. This study implies that limiting disease transmissions, such as acquiring a coronavirus disease 2019 vaccine and booster doses for those aged 18 and older, as well as wearing the mask in public places, is the best strategy to prevent the emergence of new variants. genetic lineages had emerged and transmitted over the globe. 3, 4 The US Department of Health and Human Services (HHS) established the SARS-CoV-2 Interagency Group (SIG) to focus on the rapid characterization of emerging variants and actively monitor their potential impact on critical SARS-CoV-2 countermeasures, such as immunizations, pharmaceuticals, and testing. SARS-CoV-2 variations are divided into four categories under the SIG Variant classification scheme: variants being monitored (VBM), variants of interest (VOI), variants of concern (VOC), and variants of high consequence (VOHC). 5 Variants classified as VBM are those for which data implies Delta and Omicron are two current variants of concern. In late 2020, India became the first country to identify the Delta variant. On May 31, 2021, the Delta variant was found, and by November 22, 2021 , it had spread to 179 countries. In June 2021, the World Health Organization (WHO) stated that the Delta variant would become the most common stress worldwide. It seems to have mutations T478K, P681R, and L452R in the gene encoding the SARS-CoV-2 spike protein, which become known to alter the virus's infectiousness and how it can be neutralized with antigens to recently circulating COVID-19 virus variants. It is believed as one of the very highly contagious serious infections ever discovered. [8] [9] [10] [11] [12] Public Health England (PHE) reported a 10.8% supplementary attack rate in domestic encounters of non-travel and unidentified incidents for Delta in August 2021, compared with 10.2% for the Alpha variant; the rate of incidence in those 386 835 Delta individuals is 0.3%, with 46% of incidence and 6% of mortalities being unvaccinated and under the age of 50. 13, 14 The variant is suspected of playing a role in the devastating second wave of the epidemic that began in February 2021 in India. 15 Fiji, the UK, and South Africa all suffered the third wave as a result of it. It has also contributed to an upsurge in daily attacks in Asia, the United States, Australia, and New Zealand by late July. [16] [17] [18] [19] [20] [21] [22] Omicron, another COVID variant, came next. It would be the most recent variant, as of December 2021. On November 24, 2021, South Africa was the first to report it to the World Health Organization (WHO). The WHO called it "Omicron" on November 26, 2021, and classified it as a variant of concern. The Omicron variant features an absolutely enormous genetic variation, several of which are unique, as well as a substantial proportion from which impair the spike protein attacked by most COVID-19 vaccines during the period of its discovery. [23] [24] [25] Omicron is presumed to be quite infectious than previous variants of concern, spreading 70 times faster in the alveoli than certain preceding variants, and yet this is less capable of infiltrating profound bronchial membrane, which may help us understand why there is significant prevention of serious illnesses hospitalization. 26, 27 The variation had been confirmed in over 80 countries as of December 16, 2021. Omicron, according to the World Health Organization, was likely with numerous nations as mid-December, whether or not it had been found. 28 Worldometer is a public and open-access initiative that serves worldwide COVID-19 statistics to a large number of concerned citizens all around the world; from this, we gathered data on SARS-CoV-2 infection tests conducted around the world for our research. 31 We used numerous graphs and visualizations to analyze our data Following that, the propagation coefficient is computed for those five nations to assess the spread intensity of the variants using the number of sequences and days determined by the variant identified period and sample period (Tables 1 and 2 ). The propagation rate of variants in the UK can be observed from Figure 3A, Table 3 shows the number of tests per million inhabitants in those five nations, as well as the number of sequences. Figure 4 depicts the results of the tests based on the percentages calculated in Table 3 . As in other countries, and also future mutations around the world. The authors declare no conflicts of interest. T A B L E 3 Shows the number of SARS-CoV-2 infection tests performed per million population and the number of sequences found in the UK, USA, Denmark, France, and Australia, based on data sets 1 (GISAID) and 2 (Worldometer) F I G U R E 4 Shows the percentage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection tests in the UK, United States, Denmark, France, and Australia based on Table 3 Understanding variants of SARS-CoV-2. The Lancet Tracking changes in SARS-CoV-2 spike: Evidence that D614G increases infectivity of the COVID-19 Virus SARS-CoV-2 spike D614G change enhances replication and transmission Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity SARS-CoV-2 Variants of concern in the United States -challenges and opportunities Occurrence of variants of SARS-CoV-2 in the Americas − 26 SARS-CoV-2 lineages The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus Delta coronavirus variant: scientists brace for impact A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology Cell entry mechanisms of SARS-CoV-2 Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016 Technical briefing 20 SARS-CoV-2 variants of concern and variants under investigation in England SARS-CoV-2 variants of concern and variants under investigation in England 2021 Public Health England Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion The challenges of COVID-19 Delta variant: prevention and vaccine development Analysis of the Delta variant B.1.617.2 COVID-19 Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant Australia's struggle with the delta variant Transmission of severe acute respiratory syndrome coronavirus 2 during border quarantine and Air Travel Changing composition of SARS-CoV-2 lineages and rise of Delta variant in England Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa Omicron may be more transmissible than other variants and partly resistant to existing vaccines, scientists fear OMICRON (B.1.1.529): a new SARS-CoV-2 variant of concern mounting worldwide fear Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein Highly mutated SARS-CoV-2 Omicron variant sparks significant concern among global experts -What is known so far SARS-CoV-2 Omicron variant: characteristics and prevention. MedComm (2020) SARS-CoV-2 mutations and variants of interest An exploratory study on the propagation of SARS-CoV-2 variants: omicron is the most predominant variant Both authors contributed equally. The data that support the findings of this study are openly available in GISAID database at https://covariants.org/. https://orcid.org/0000-0001-7322-8653